Brilliant Violet 510™ anti-human IL-4
Description
IL-4 is a pleiotropic cytokine that is produced by activated T cells, mast cells, and basophils. IL-4 elicits many different biological responses but has two dominant functions. The first is regulating differentiation of naïve CD4+ T cell to the Th2 type. Th2 cells produce IL-4, IL-5, IL-10, and IL-13, which tend to favor a humoral immune response while suppressing a cell-mediated immune response controlled by Th1 cells. The second is regulating IgE and IgG1 production by B cells.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤5 microL per million cells or 5 microL per 100 microL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
Brilliant Violet 510™ excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510™ is a trademark of Sirigen Group Ltd.
References
1. Chretien I, et al. 1989. J. Immunol. Methods 117:67. (ELISA Detection, Neut)
2. Ramanathan L, et al. 1993. Biochem. 32:3549. (Neut)
3. Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA Detection, Neut)
4. Mahanty S, et al. 1992. J. Immunol. 148:3567. (ELISPOT Detection)
5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons New York. Unit 6.19. (ELISPOT Detection)
6. Prussin C, et al. 1995. J. Immunol. Methods 188:117. (ICFC)
7. Raqib R, et al. 1995. Infect. Immun. 63:289.
8. Andersson J, et al. 1994. Immunology 83:16.
9. Iwamoto S, et al. 2007. J. Immunol. 179:1449. (ICFC) PubMed
10. Kubota M, et al. 1997. J. Immunol. 158:5321.
11. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. PubMed
12. Kroneke MA, et al. 2012. J. Immunol. 188:3734. PubMed